These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16971663)

  • 1. Increased chondroitin sulphate proteoglycan expression (B5 immunoreactivity) in metastases of uveal melanoma.
    Kiewe P; Bechrakis NE; Schmittel A; Ruf P; Lindhofer H; Thiel E; Nagorsen D
    Ann Oncol; 2006 Dec; 17(12):1830-4. PubMed ID: 16971663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HNK-1 antigens on uveal and cutaneous melanoma cell lines.
    Tang NE; Luyten GP; Mooy CM; Naus NC; de Jong PT; Luider TM
    Melanoma Res; 1996 Dec; 6(6):411-8. PubMed ID: 9013478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion.
    Faassen AE; Schrager JA; Klein DJ; Oegema TR; Couchman JR; McCarthy JB
    J Cell Biol; 1992 Jan; 116(2):521-31. PubMed ID: 1730766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nestin expression in primary and metastatic uveal melanoma - possible biomarker for high-risk uveal melanoma.
    Djirackor L; Shakir D; Kalirai H; Petrovski G; Coupland SE
    Acta Ophthalmol; 2018 Aug; 96(5):503-509. PubMed ID: 29338117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic uveal melanoma. A morphologic and immunohistochemical analysis.
    Luyten GP; Mooy CM; Post J; Jensen OA; Luider TM; de Jong PT
    Cancer; 1996 Nov; 78(9):1967-71. PubMed ID: 8909318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma.
    de Vries TJ; Trancikova D; Ruiter DJ; van Muijen GN
    Br J Cancer; 1998 Nov; 78(9):1156-61. PubMed ID: 9820172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.
    All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin expression in uveal melanoma differs from cutaneous melanoma.
    ten Berge PJ; Danen EH; van Muijen GN; Jager MJ; Ruiter DJ
    Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3635-40. PubMed ID: 8258522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers.
    Khatib N; Pe'er J; Ortenberg R; Schachter J; Frenkel S; Markel G; Amer R
    Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9368-72. PubMed ID: 22039239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-MET expression in primary and liver metastases in uveal melanoma.
    Gardner FP; Serie DJ; Salomao DR; Wu KJ; Markovic SN; Pulido JS; Joseph RW
    Melanoma Res; 2014 Dec; 24(6):617-20. PubMed ID: 25211165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of insulin-like growth factor-1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth.
    Yoshida M; Selvan S; McCue PA; DeAngelis T; Baserga R; Fujii A; Rui H; Mastrangelo MJ; Sato T
    Pigment Cell Melanoma Res; 2014 Mar; 27(2):297-308. PubMed ID: 24354797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns.
    Folberg R; Arbieva Z; Moses J; Hayee A; Sandal T; Kadkol S; Lin AY; Valyi-Nagy K; Setty S; Leach L; Chévez-Barrios P; Larsen P; Majumdar D; Pe'er J; Maniotis AJ
    Am J Pathol; 2006 Oct; 169(4):1376-89. PubMed ID: 17003493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of anti-ganglioside antibodies on the metastatic spread of intraocular melanomas in a nude mouse model of human uveal melanoma.
    Niederkorn JY; Mellon J; Pidherney M; Mayhew E; Anand R
    Curr Eye Res; 1993 Apr; 12(4):347-58. PubMed ID: 8319494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eyelids metastases from uveal melanoma: clinical and histopathologic features of two cases and literature review.
    Martel A; Oberic A; Moulin A; Zografos L; Hamedani M
    Eye (Lond); 2019 May; 33(5):767-771. PubMed ID: 30560912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the role of BAFF as biomarker in the detection of uveal melanoma metastases.
    Lin Z; Süsskind D
    J Cancer Res Clin Oncol; 2021 May; 147(5):1389-1405. PubMed ID: 33665679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of fluorescence in situ hybridization to distinguish metastatic uveal from cutaneous melanoma.
    Fang Y; Wang X; Dusza S; Jhanwar S; Abramson D; Busam KJ
    Int J Surg Pathol; 2012 Jun; 20(3):246-51. PubMed ID: 22415057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma.
    Shah AA; Bourne TD; Murali R
    Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunohistochemical analysis of nm23 gene product expression in uveal melanoma.
    Greco IM; Calvisi G; Ventura L; Cerrito F
    Melanoma Res; 1997 Jun; 7(3):231-6. PubMed ID: 9195562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
    Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
    Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and distribution of MUC18 in human uveal melanoma.
    Lai K; Sharma V; Jager MJ; Conway RM; Madigan MC
    Virchows Arch; 2007 Nov; 451(5):967-76. PubMed ID: 17786470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.